NPRA approves clinical study of another COVID-19 vaccine - Health DG
The National Pharmaceutical Regulatory Agency (NPRA) has approved a clinical study of another COVID-19 vaccine, said Health director-general Tan Sri Dr Noor Hisham Abdullah.
Sat Jun 05 2021
COVID-19: 3.5 pct vaccine recipients experience mild to serious side effects
From those with side effects, 3,676 cases were detected by the National Pharmaceutical Regulatory Agency (NPRA) and 22,094 cases through MySejahtera.
Fri Apr 02 2021
All COVID-19 vaccines approved by NPRA, people need not be concerned about brands - PM
Muhyiddin said all the vaccines used in the National COVID-19 Immunisation Programme (PICK) have been tested safe and effective by NPRA.
Fri Mar 05 2021
Four COVID-19 vaccine candidates await NPRA approval
Four COVID-19 vaccine candidates are in the process of being approved by the National Pharmaceutical Regulatory Agency (NPRA), according to the National COVID-19 Immunisation Programme Handbook.
Tue Feb 16 2021
NPRA yet to receive COVID-19 vaccine evaluation registration document from Pfizer - MOH
The Health Ministry's National Pharmaceutical Regulatory Agency (NPRA) has so far not received any documents from Pfizer for evaluation registration and testing of the COVID-19 vaccine.
Sun Dec 06 2020